Alberto A. Mendivil – 医学博士、资深研究员

职位:妇产科/妇科肿瘤专家
科室:肿瘤专科
擅长:妇产科,妇科肿瘤
执业证书编号:A 90983

执业认证

美国妇产科医学委员会——妇产科(Obstetrics and Gynecology)认证
美国妇产科医学委员会——妇科肿瘤(Gynecological Oncology)认证

立即预约

医疗专长

Alberto A. Mendivil, M.D(阿尔贝托A.门迪威尔医学博士)接受了全方位的妇科手术训练,包括先进的腹腔镜和机器人手术。临床擅长通过微创外科手术进行妇科肿瘤分期和治疗、使用达芬奇机器人进行保留生育能力的妇科肿瘤外科手术等;是美国妇科腹腔镜协会(AAGL)微创妇科手术卓越中心的指定医生。

Dr. Mendivil临床诊疗侧重妇科肿瘤疾病,包括子宫肌瘤、子宫癌、子宫颈癌、输卵管癌、卵巢癌、阴道癌、会阴部癌症等,同时也开展妇产科常规疾病诊疗,包括子宫内膜异位症、盆腔炎、卵巢囊肿、多囊卵巢综合征、宫颈息肉、更年期和绝经后失调、异常阴道出血、乳房疾病、外阴和阴道念珠菌病、生殖器疱疹、复杂妊娠或分娩等。

教育背景

本科教育:圣地牙哥加利福尼亚大学(University of California, San Diego),动物生理学和神经科学专业,1998年毕业获得理学士学位;
医学教育:犹他大学医学院(University of Utah School of Medicine),2003年毕业获得医学博士学位;
实习与住院医培训:加州大学欧文分校医学中心(University of California, Irvine Medical Center)妇科与产科训练;
专科培训:教堂山北卡罗莱纳大学(University of North Carolina, Chapel Hill)妇产科部门,妇科肿瘤(Gynecologic Oncology)专科培训。

合作医院

长老会霍格纪念医院(Hoag Memorial Hospital Presbyterian)

波莫纳谷医院医疗中心(Pomona Valley Hospital Medical Center)

领导才能

1999-2000年,任犹他大学医学院“少数民族医学生协会”联合主席
2000-2001年,犹他大学医学院代表,学院研究员,国家医学奖学金获得者
2001年,任犹他大学医学院妇产科部门,学生顾问委员会成员
2000-2001,2002-2003年,任犹他大学医学院,任执行委员会成员和校友会董事会成员
2002-2003年,担任犹他大学医学院学生会联合主席
2005年,任加州大学欧文分校本科课程“Life of Medicine”的联合讲师
2005-2006年,任美国妇产科学会第九区初级研究员,第七区主席
2006-2007年,任加州大学欧文分校医学中心,妇产科行政总住院医师

荣誉与奖项

1993年,荣获“David Holmgren纪念奖学金”;
1997年,荣获圣地牙哥加利福尼亚大学“Howard Hughes研究津贴”;
1999-2000年,荣获“Dean A. Moffat, M.D.纪念奖学金”、“Bernett Love纪念奖学金”;
2000年,荣获“Betty Ford中心奖学金”、“国家医学奖学金”、“犹他医学院医学生研究奖学金”;
2000-2001年,荣获“Robert Wood Johnson基金会奖”、“Edward C. Klatt, M.D.奖学金”、“Edward C. Klatt, M.D.奖学金”;
2001年,荣获“Herbert W. Nickens, M.D. 少数民族医学生奖学金”、“国家医学奖学金”、“西方学生医学研究奖学金”;
2002年,荣获“Linda Derrick Wood奖学金”和“内分泌学会研究奖学金”;

2003年,荣获犹他大学医学院“校友会学生奖”;
2005年6月,荣获加州大学欧文分校妇产科部“第二年住院医师教学奖”;
2005年6月,荣获加州大学欧文分校医学院“住院医师教学奖”;
2007年6月,荣获加州大学欧文分校医学院“住院医师教学奖”;
2007年6月,荣获Philip J. DiSaia, MD加州大学欧文分校“医学生教学奖”;
2008年9月,获评大西洋中部妇科肿瘤协会年会“最佳演讲者(Best Fellow Presentation)”。
2002年,荣获百时美施贵宝NMF学术医学研究奖学金;

专业协会

2000-2003年,全美西班牙裔医师协会(National Hispanic Medical Association)
2004年至今,美国妇产科医生协会(American College of Obstetricians and Gynecologists)
2003-2007年,加州橙县医学会(Orange County California Medical Association)
2007年至今,妇科肿瘤医师学会(Society of Gynecologic Oncologists)
2008年至今,大西洋中部的妇科肿瘤协会(Mid-Atlantic Gynecologic Oncology Society)
2008年至今,美国外科医师学会(American College of Surgeons)
2012年,美国妇科腹腔镜协会-微创妇科手术卓越中心-指定外科医生(American Association of Gynecologic Laparoscopy,Center of Excellence in Minimally Invasive Gynecologic Surgery,
Surgeon Designee)

操作技术

Abdominal Hysterectomy With Robotic Assistance机器人辅助的腹式子宫切除术

Colon and Rectal Surgery结肠和直肠手术

Colpopexy阴道固定术

Colpopexy With Robotic Assistance机器人辅助的阴道固定术

Colporrhaphy阴道缝合术

Destruction or Excision of Lesion of Cervix (incl. LEEP)宫颈病变切除术(包括环形电切术)

Destruction or Excision of Vaginal Lesions阴道病变切除术

Endocervical Curettage宫颈刮除术

Excision of Cervix宫颈切除术

Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer皮肤及皮下组织切除、修整或消灭(包括莫氏显微手术),组织移植

Hysterectomy – Laparoscopic腹腔镜子宫切除术

Hysterectomy – Open开放式子宫切除术

Hysteroscopy子宫镜检查

Incision and Removal of Foreign Object外物移除或切开

Laparoscopic Surgical Procedure腹腔镜外科手术

Laparoscopic Vaginal Hysterectomy With Robotic Assistance机器人辅助的腹腔镜经阴道子宫切除术

Laparotomy剖腹手术

Lymph Node Biopsy or Excision淋巴结活检或切除

Lymphadenectomy With Robotic Assistance机器人辅助的淋巴切除术

Myomectomy – Open and-or Laparoscopic开放式肌瘤切除术或腹腔镜肌瘤切除术

Osteoporosis Screening骨质疏松症的筛查

Pap Smear子宫颈抹片检查

Pelvic Exenteration (For: Gynecologic, Urinary, or Colorectal Malignancy)盆腔廓清术(用于妇科、泌尿系统或结直肠恶性肿瘤)

Puncture Aspiration穿刺抽吸

Removal of Reproductive Organs (Hysterectomy, Oophorectomy, Salpingectomy, Salpingo-Oophorectomy, Resection of Peritoneal Malignancy)生殖器官切除术(子宫、卵巢切除术、输卵管切除术、输卵管卵巢切除术,切除腹膜恶性肿瘤)

Rh Incompatibility ScreeningRh不容性筛选

Thyroid Screening甲状腺筛查

Total Salpingectomy With Robotic Assistance机器人辅助的总输卵管切除术

Vaginal Surgery阴道手术

Vaginectomy阴道切除术

Vulvectomy外阴切除术

Wound Repair伤口修复术

同行评议出版物

Mendivil AA, Goldstein BH. Reply: Radical Hysterectomy and Survival Outcomes in the Management of Early Stage Cervical Cancer Surgical Oncology. Surg Oncol 2016; 25: 123.

Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, Goldstein BH. Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: A five year experience. Surg Oncol 2016; 25: 66-71.

Micha JP, Rettenmaier MA, Brown III JV, Mendivil AA, Abaid LN, Lopez KL, Goldstein BH. A randomized, controlled pilot study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting in patients treated for gynecologic cancer. Int J Gynecol Cancer. 2016; 26:389-393.

Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Lopez KL, Goldstein BH. Dramatically reduced incidence of vaginal cuff dehiscence in gynecologic patients undergoing endoscopic closure with barbed sutures: A retrospective cohort study. Int J Surg 2015; 19:27-30.

Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV 3rd, Micha JP, Wilcox AM, Goldstein BH.
The feasibility of administering varying high-dose consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of ovarian carcinoma
Arch Gynecol Obstet 2015; 291:1381-6.

Rettenmaier MA, Mendivil AA, Gray CM, Chapman AP, Stone MK, Tinnerman EJ, Goldstein BH. Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma. Int J Hyperthermia 2015; 24:1-7.

Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, Goldstein BH. A comparison of open surgery, robotic-assisted surgery and conventional laparoscopic surgery in the treatment of morbidly obese endometrial cancer patients. JSLS 2015;19: 1-5.

Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV, Wilcox AM, Goldstein BH. Consolidation Hyperthermic Intraperitoneal Chemotherapy and Maintenance Chemotherapy Following Laparoscopic Cytoreductive Surgery in the Treatment of Advanced Stage Ovarian Carcinoma. Int J Hyperthermia 2015;31:8-14.

Brown JV, Mendivil AA, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH. The Safety and Feasibility of Robotic Lymph Node Staging in Early-Stage Ovarian Cancer. Int J Gynecol Cancer 24(8) 2014.

Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Micha JP, Goldstein BH. The incidence of postprandial nausea and nutritional regression in gynecologic cancer patients following intestinal surgery: A retrospective cohort study. Int J Surg 2014; 12: 783-787.

Mendivil AA, Micha JP, Stallman JM, Goldstein BH. A Very Rare Case of Vaginal Angiokeratoma. Euro J Gynaecol Oncol 2014; 3: 313-315.

Mendivil AA, Brown III JV, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH. Robotic-Assisted Surgery for the Treatment of Pelvic Masses in Pregnant Patients: A Series of Four Cases and Literature Review.J Robot Surg 2013; 7: 333–337. Care 2013; 2: 124.

Mendivil AA, Cupp JS, Van Dalsem W, Caffarelli A, Goldstein BH. Multidisciplinary treatment of pelvic and cardiac intravenous leiomyosarcomatosis. Gynecol Oncol 2013; 6: 16–18.

LN, Micha JP, Rettenmaier MA, Brown JV, Mendivil AA, Lopez KL, Goldstein BH. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma. Cancer Chemother Pharmacol 2013;72:101-107.

Micha JP, Brown JV, Rettenmaier MA, Abaid LN, Mendivil AA, Lopez KI, Goldstein BH. Pegfilgrastim safely administered on the same day as dose-dense chemotherapy for patients with advanced-stage ovarian cancer. Clin Oncol 2013; Feb (letter).

Mendivil AA, Micha JP, Brown JV 3rd, Rettenmaier MA, Abaid LN, Lopez KL, Goldstein BH. Increased incidence of severe gastrointestinal events with first-line Paclitaxel, Carboplatin, and Vorinostat chemotherapy for advanced-stage epithelial ovarian, primary peritoneal, and fallopian tube cancer. Int J Gynecol Cancer 2013;23:533-9.

Mendivil AA, Stallman JM, Chad JN, Goldstein BH. An Unusual Case of Fallopian IntraepithelialTube Carcinoma with Mucinous Goblet Cell Differentiation. Gynecol Oncol 2012; 2: 47-50.Micha JP, Mendivil AA, Cupp JS, Goldstein BH. Recurrent Lymphatic Ascites in a Patient Cured of CervicalCarcinoma. Gyn Oncol 2012; 2: 105-106.

Mendivil AA, Abaid L, Epstein HD, Rettenmaier MA, Brown JV 3rd, Micha JP, Wabe MA, Goldstein BH. Paget’s disease of the vulva: a clinicopathologic institutional review. Int J Clin Oncol 2012; 17:569-74.

Rettenmaier MA, Mendivil AA, Brown JV III, Abaid LN, Micha JP, Goldstein BH. Same Day Discharge in Clinical Stage 1 Endometrial Cancer Patients Treated with Total Laparoscopic Hysterectomy, Bilateral Salpingoophorectomy and Bilateral Pelvic Lymphadenectomy. Oncol 2012;82:321-326

Abaid LN, Rettenmaier MA, Brown III JV, Micha JP, Mendivil AA, Wabe MA, Goldstein BH. Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer. J Gynecol Oncol 2012; 23: 22-27.

Mendivil AA, Abaid LN, Epstein HD, Rettenmaier MA, Brown JV III, Micha JP, Wabe MA, Goldstein BH. Paget’s Disease of the Vulva: A Clinicopathologic Institutional Review. Int J Clin Oncol 2012; 17:569-74.

Mendivil A, Rettenmaier MA, Cox C, Abaid LA, Brown JV, Micha JP, Lopez KL, Goldstein BH. Acute and Delayed Complications from Surgery and Adjuvant Radiotherapy in the Treatment of High Risk Endometrial and Cervical Cancer. 2011 Oncology, 81:79-83.

Micha JP, Mendivil A, Epstein HD, LaFlamme LA, Goldstein BH. An Unusual Case of Endometrioid Adenocarcinoma Arising from Endometriosis. 2011 J Repro Med, manuscript accepted for publication.

Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Mallory KM, Bae-Jump VL. AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. 2011 Repro Sci, manuscript accepted for publication.

Cantrell LA, Mendivil A, Gehrig PA, Boggess JF. Survival Outcomes for Women Undergoing Type III Robotic Radical Hysterectomy for Cervical Cancer: A 3-year experience. 2010 Gynecol Oncol, 117(2):260-5.

Cantrell LA, Zhou C, Mendivil A, Gehrig PA, Malloy KM, Bae-Jump VL. Metformin is a potent inhibitor of endometrial cancer cell proliferation – implications for a novel treatment strategy. 2009 Gyncol Oncol, 116(1): 92-98.

Boggess JF, Gehrig PA, Cantrell LA, Shafer A, Mendivil A, Rossi E, Hanna R. Perioperative outcomes of robotically assisted hysterectomy for benign cases with complex pathology. 2009 Obstet Gynecol, 114(3).

Mendivil A, Holloway RW, Boggess JF. Invited Review: Emergence of robotic assisted surgery in gynecologic oncology: American perspective. 2009 Gynecol Oncol, 114(2): S24-S31.

Mendivil A, Schuler KM, Gehrig PA. Invited Review: Non-Endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. 2009 Cancer Control, 16(1): 46-52.

Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Boggess JF. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? 2008 Gynecol Oncol, 111(1): 41-45.

Yessaian A, Mendivil A, Brewster WR. Population characteristics in cervical cancer trials: Search for external validity. 2005 Am J Obstet Gynecol, 192(2): 407-13.

La Cava A, Massa M, Mendivil A, Martini A, Albani S. Genetic Immunization Maps T Cell (Auto) Immune Responses to Self Antigens Homologous to Exogenous Proteins. 2002 Autoimmunity, 35(2): 105-10.

Prakken B, Wauben M, Genini D, Samodal R, Barnett J, Mendivil A, Leoni L, Albani S. Artificial antigen-presenting cells as a tool to exploit the immune ‘synapse’. 2000 Nature Medicine, 6(12): 1406-10.

书本章节

Mendivil A, Boggess JF. Robotic Surgery in Gynecologic Oncology. In: Textbook in Gynaecologic Oncology (ESGO ENYGO Endorsed). Edited by Ayhan, Gultekin, Dursun. Publisher: Gunes Kıtabevleri, 2011.

Mendivil A, Fowler WC. Early epithelial ovarian cancer. In: Gynecological Cancer Management: Identification, Diagnosis, and Treatment. D Clarke-Pearson, JT Soper (eds) 2009. Publisher: Wiley-Blackwell, 2010

Mendivil A, Bae-Jump VL. Germ cell tumors. In: Gynecological Cancer Management: Identification, Diagnosis, and Treatment. D Clarke-Pearson, JT Soper (eds) 2009. Publisher: Wiley-Blackwell, 2010

Mendivil A, Clarke-Pearson D. Gynecological Cancer Management: Identification, Diagnosis, and Treatment. D Clarke-Pearson, JT Soper (eds) 2009. Publisher: Wiley-Blackwell, 2010

Mendivil A, Boggess JF. Robotic Surgery in Gynecologic Oncology. In: Textbook in Gynaecologic Oncology (ESGO ENYGO Endorsed). Edited by Ayhan, Gultekin, Dursun. Publisher: Gunes Kıtabevleri, 2009

演讲

BRCA and the Hereditary Breast/ Ovarian Cancer Syndrome. Grand Rounds presented at Nash Regional Medical Center, Rocky Mount, NC, April 14, 2009.

Gynecologic Surgery in the Obese Patient. Grand Rounds presented at the New Hanover Regional Medical Center, Wilmington, NC, March 6, 2009.

Robotic Surgery Training in Gynecologic Oncology: A Comparison of Fellow and Attending Surgical Times. Presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 5, 2009.

A Three-Year Analysis of Endometrial Cancer Staging via Robotic Assistance. Presented at the 2nd Annual Meeting of the International Gynecologic Oncology Robotics Symposium, Chapel Hill, NC, November 10, 2008.

A Fellow and Attending Surgeon Comparison of Robotic Surgical Outcomes in A Fellowship Training Program. Presented at the 2nd Annual Meeting of the International Gynecologic Oncology Robotics Symposium, Chapel Hill, NC, November 10, 2008.

Metformin’s Effects on Endometrial Cancer. Presented at the 23rd Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society, Washington, DC, September 20, 2008.

Growth of Robotic Surgery Among Gynecologic Oncologists. Presented at the 23rd Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society, Washington, DC, September 20, 2008.

Management of Primary Peritoneal and Fallopian Tube Carcinomas: Are they similar to Epithelial Ovarian Cancer? 25th Annual Philip J. DiSaia Resident Paper Day. UCI Department of Obstetrics and Gynecology. Orange, CA. May 12, 2007.

Absence of Cardiotoxicity with Long-Term Use of Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer. 24th Annual Philip J. DiSaia Resident Paper Day. UCI Department of Obstetrics and Gynecology. Costa Mesa, CA. May 19, 2006.

研究展示

Micha JP, Rettenmaier MA, Brown III JV, Mendivil AA, Abaid LN, Lopez KL, Goldstein BH. A phase IV, randomized study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting and activities of daily living in patients treated for gynecologic cancer. European Society of Gynaecological Oncology Annual Meeting; October 2015: Nice, FR.

MA, Mendivil AA, Abaid LN, Brown III JV, Micha JP, Wilcox AM, Goldstein BH. Consolidation Hyperthermic Intraperitoneal Chemotherapy and Maintenance Chemotherapy FollowingLaparoscopic Cytoreductive Surgery in the Treatment of Ovarian Carcinoma. International Gynecologic Cancer Society Annual Meeting; May 2015: Santiago, CL.

Rettenmaier MA, Abaid LN, Brown JV III, Micha JP, Lopez KL, Goldstein BH. A Comparison of Open Surgery, Robotic-Assisted Surgery and Conventional Laparoscopic Surgery in the Treatment of Morbidly Obese Endometrial Cancer Patients. ESJO Annual Meeting; October 2013: Liverpool, UK.

Abaid LN, Micha JP, Rettenmaier MA, Brown JV, Mendivil AA, Lopez KL, Goldstein BH. A Phase II Study of Modified Dose-Dense Paclitaxel and Every 4 week Carboplatin for the Treatment of Advanced Stage Primary Epithelial Ovarian, Fallopian Tube, or PeritonealCarcinoma. March 2012 Society of Gynecologic Oncology Meeting, Austin, TX.

Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Malloy KM, and Bae-Jump VL: Rapamycin potentiates the effects of paclitaxel in uterine papillary serous carcinoma (UPSC) cells through inhibition of cell proliferation and induction of apoptosis. Abstract presented at the Annual meeting of the American Association for Cancer Research, Washington, DC, April 2010.

O’Malley DM, Achenbach S, Skaznik-Wikiel M, Nakayama JM, Mendivil A, Havrilesky LJ, Secord AA, DeBernardo R, Gehrig PA, Fader AN: Improved survival with chemotherapy and radiation in advanced-stage uterine clear cell carcinoma. Abstract presented at the Annual Meeting of the Society of Gynecologic Oncologists, San Francisco, CA, March 2010.

O’Malley DM, Nakayma J, Secord AA, DeBernardo R, Gehrig PA, Fader AN, Mendivil A, Cohn DE, Skaznik-Wikiel M, Havrilesky L: Benefit of Adjuvant Therapy in Early Stage Clear Cell Cancer of the Uterus? Abstract presented at the Annual Meeting of the Society of Gynecologic Oncologists, San Francisco, CA, March 2010.

Mendivil A, Vogel TJ, Gehrig PA: A survival comparison between women with uterine serous and/or clear cell carcinoma with and without a history of breast cancer. Abstract presented at the Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, May 2009.

Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Malloy KM, Bae-Jump VL: AMG 479, a novel IGF-1R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. Abstract presented at the Annual Meeting of the American Association for Cancer Research, Denver, CO, April 2009.

Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Malloy KM, Bae-Jump VL: AMG 479, a novel IGF-1R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. Abstract presented at the Annual UNC Women’s Health Research Day Conference, Chapel Hill, NC, April 2009.

Mendivil A, Cantrell LA, Gehrig PA, Boggess JF: Survival Outcomes for Women Undergoing Robotic Surgery for Endometrial Cancer: A Three-Year Experience. Abstract presented at the Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.

Cantrell LA, Mendivil A, Zhou C, Gehrig PA, Bae-Jump VL: Metformin is a potent inhibitor of endometrial cancer cell proliferation- implications for a novel treatment strategy. Abstract presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.

Cantrell LA, Mendivil A, Gehrig PA, Boggess JF: Survival Outcomes for Women Undergoing Robotic Surgery for Cervical Cancer: A Three-Year Experience. Abstract presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.

Hanna R, Cantrell LA, Gehrig PA, Mendivil A, Boggess JF: A cost analysis of robotic as compared to conventional laparoscopy for endometrial cancer staging. Abstract presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.

Boggess JF, Shafer A, Cantrell LA, Abaid L, Mendivil A, Gehrig PA: Robotically Assisted Type III Radical Hysterectomy in a Morbidly Obese Woman. Abstract at the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa Bay, FL, March 2008.

Mendivil A, Hunter MI, Han E, Tewari KS: Management Of Primary Peritoneal And Fallopian Tube Carcinomas In The Platinate-Taxane Era. Abstract at the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa Bay, FL, March 2008.

Gehrig PA, Cantrell LA, Shafer A, Abaid L, Mendivil A, Boggess JF: What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? Abstract at the 39thAnnual Meeting of the Society of Gynecologic Oncologists, Tampa Bay, FL, March 2008.

Hunter MI, Ziogas A, Mendivil A, Brewster WR: Second primary breast cancer after epithelial ovarian cancer and tumors of low malignant potential. Abstract at the 39th Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, CA, April 2005.

Mendivil A, Cole BC, Sawitzke A: Mapping B-cell epitopes on mycoplasma arthritidis mitogen (MAM) using lambda phage display peptide library. Abstract at the Western Student Medical Research Forum, Deer Valley, UT, February 2001.

Prakken B, Samodal R, Mendivil A, Bonnin D, Lanza P, Amox D, Roord S, DeKleer I, Jones M, Carson D, Albani S. An E. coli Heat Shock Protein dnaJ Peptide Homologous To The “Shared Epitope” Is A Trigger Of Pro-Inflammatory, TH-1 Type T Cell Responses In Patients With Early Rheumatoid Arthritis (RA). Abstract at the Annual Meeting of the American College of Rheumatology, San Diego, CA, May 1998.

Samodal R, Louie S, Amox D, Bonnin D, Yang X, Weaver B, Mendivil A, Prakken B, Carson D, Albani S. Immunomodulatory Effects Of Treatment With A “Shared Epitope” Peptide In Patients With Rheumatoid Arthritis. Abstract at the Annual Meeting of the American College of Rheumatology, San Diego, CA, May 1998.